Oncology: Hepatitis B serology testing and prophylactic treatment prior to receiving anti-CD20 targeting drugs - ICD-10-CM Quality Payment Program Measure
| Quality Measure | Description | High Priority | Submission Methods |
|---|---|---|---|
| Oncology: Hepatitis B serology testing and prophylactic treatment prior to receiving anti-CD20 targeting drugs | Percentage of patients tested for Hepatitis B prior to receiving anti-CD20 targeting treatment, including rituximab, ofatumumab, and Obinutuzumab; patients testing positive for Hepatitis B receive prophylactic treatment. | YES | Registry |
Linked ICD-10 Codes
The following ICD-10-CM codes are linked to the quality measure oncology: hepatitis b serology testing and prophylactic treatment prior to receiving anti-cd20 targeting drugs when used as part of a patient's medical record. This Quality Measure is part of Medicare's Quality Payment Program (QPP).
| ICD Code | Description | Category |
|---|